Inmune Bio, Inc. — All Filings
578 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B3
424B5
8-A12B
8-A12B/A
8-K
8-K/A
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | CURRENT REPORT | 0001213900-26-021120 | Feb 27, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-019321 | Feb 23, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-018396 | Feb 19, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-016385 | Feb 13, 2026 | Feb 10, 2026 |
| 8-K | CURRENT REPORT | 0001213900-26-008204 | Jan 27, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-25-125282 | Dec 23, 2025 | Dec 22, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-123880 | Dec 19, 2025 | — |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-123817 | Dec 19, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-120067 | Dec 10, 2025 | Dec 5, 2025 |
| 8-A12B/A | AMENDMENT NO. 5 TO FORM 8-A12B | 0001213900-25-119251 | Dec 8, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-119217 | Dec 8, 2025 | Dec 5, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-118699 | Dec 5, 2025 | Dec 1, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-117828 | Dec 3, 2025 | Dec 2, 2025 |
| 4 | — | 0001213900-25-117311 | Dec 2, 2025 | Dec 1, 2025 |
| 4 | — | 0001213900-25-117309 | Dec 2, 2025 | Dec 1, 2025 |
| 4 | — | 0001213900-25-117306 | Dec 2, 2025 | Dec 1, 2025 |
| 4 | — | 0001213900-25-117305 | Dec 2, 2025 | Dec 1, 2025 |
| 4 | — | 0001213900-25-117303 | Dec 2, 2025 | Dec 1, 2025 |
| 4 | — | 0001213900-25-117302 | Dec 2, 2025 | Dec 1, 2025 |
| 4 | — | 0001213900-25-117300 | Dec 2, 2025 | Dec 1, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-115921 | Nov 28, 2025 | Nov 26, 2025 |
| 4 | — | 0001213900-25-112241 | Nov 18, 2025 | — |
| 4 | — | 0001213900-25-112239 | Nov 18, 2025 | — |
| 4 | — | 0001213900-25-112236 | Nov 18, 2025 | — |
| 4 | — | 0001213900-25-112232 | Nov 18, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001213900-25-112229 | Nov 18, 2025 | — |
| 4 | — | 0001213900-25-112227 | Nov 18, 2025 | — |
| 4 | — | 0001213900-25-112223 | Nov 18, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-112136 | Nov 18, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-108315 | Nov 10, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-104154 | Oct 30, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-104141 | Oct 30, 2025 | Sep 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-103068 | Oct 28, 2025 | Oct 23, 2025 |
| DEF 14A | PROXY STATEMENT | 0001213900-25-098715 | Oct 14, 2025 | Nov 18, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-098702 | Oct 14, 2025 | — |
| PRE 14A | PROXY STATEMENT | 0001213900-25-096059 | Oct 3, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-093930 | Sep 30, 2025 | Sep 29, 2025 |
| 3 | — | 0001213900-25-078041 | Aug 18, 2025 | Aug 4, 2025 |
| SCHEDULE 13G/A | — | 0000902664-25-003626 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001649553-25-000155 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000921895-25-002270 | Aug 14, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-073089 | Aug 7, 2025 | Aug 4, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-073077 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-068745 | Jul 29, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-067791 | Jul 25, 2025 | Jul 24, 2025 |
| SCHEDULE 13G | — | 0001649553-25-000121 | Jul 2, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-059690 | Jun 30, 2025 | Jun 27, 2025 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-25-059298 | Jun 30, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-059252 | Jun 30, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-058380 | Jun 26, 2025 | — |